The capability of simultaneous clinical development between China and the United States, and the first-class service team with in-depth knowledge in both countries, that’s what makes CR Medicon Inc. the best choice for your clinical development.
CR Medicon can provide full scope of clinical development services for clients, including Regulatory Affairs, Medical Affairs, Clinical Operation, Bioanalysis, Data Management and Statistical Analysis, etc. Founded in January, 2017, it has become a CRO partner of many well-known China local and global sponsors within a short time.
CR Medicon has an excellent data management and statistical analysis team. During clinical trial design and protocol finalization stage, our senior Statisticians can provide expert advice from statistical perspective. At critical project timepoints, such as database going live, database lock and statistical analysis report, our team can meet the sponsor’s time requirement as much as possible without lowering the service quality. Our team have rich experience in FDA submission projects, and our service quality can fully satisfy regulatory requirements of FDA.
At each step of clinical development, CR Medicon is able to provide best service for clients, which can save time and cost, and improve the quality for drug research and development. CR Medicon will prove to be your best choice for CRO service.